Search for: "AstraZeneca Pharmaceuticals, LP"
Results 101 - 116
of 116
Sorted by Relevance
|
Sort by Date
13 May 2010, 12:27 pm
Astrazeneca Pharmaceuticals LP, 2009 WL 2231686 (M.D. [read post]
3 Jan 2012, 10:20 am
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352 (11th Cir. 2011). [read post]
29 Dec 2011, 6:53 am
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352 (11th Cir. 2011). [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
29 Dec 2010, 12:54 pm
In a transparent attempt to hamstring pharmaceutical marketing, the state of Vermont made it illegal for data miners to sell physician prescribing information to pharmaceutical companies. [read post]
2 Oct 2008, 12:36 pm
Astrazeneca Pharmaceuticals, LP, 500 F.Supp.2d 736 (S.D. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb), EU: Pharmaceutical sector enquiry regarding possible misuse of IP rights: (GenericsWeb), India: Indian government seeks to be a leader in deep sea bed mining to provide competitive edge for pharmaceutical companies in the development of new drugs: (Spicy IP),India : Medical Devices Regulation Bill formulated: (Spicy IP),India : Pharma gets bigger - Novo Nordisk and Merck & Co expansion plans: (Spicy IP),India : US patent reform and the Indian generics… [read post]
24 Sep 2010, 7:00 am
Goldfield, Civil Action No. 10-CV-4430-ER (E.D.P.A.): In this case, the SEC alleges that Self, an Executive Director of Business Development at a pharmaceutical company and Goldfield, a former hedge fund manager, engaged in unlawful insider trading in advance of the April 23, 2007 announcement that AstraZeneca would acquire MedImmune, Inc. [read post]
4 Dec 2009, 5:00 am
See AstraZeneca LP v. [read post]
8 Dec 2015, 2:22 pm
AstraZeneca LP and Cephalon Inc. paid the United States $26.7 million and $4.3 million, respectively, in separate settlements for allegedly underpaying rebates owed under the Medicaid Drug Rebate Program. [read post]
5 Aug 2021, 12:12 pm
(collectively, GSK) sued Teva Pharmaceuticals USA, Inc. in the United States District Court for the District of Delaware for infringement of claims of GSK’s Reissue Patent No. [read post]
25 Jan 2010, 5:00 am
As we said last week, because it’s a Dechert case, we can’t comment directly on Clark v. [read post]
3 May 2014, 8:56 am
Merrell Dow Pharmaceuticals, Inc., 89 F.3d 594, 596-98 (9th Cir. 1996) (affirming exclusion of Dr. [read post]
15 Apr 2009, 4:44 am
Astrazenaca Pharmaceuticals, LP, 223 F.R.D. 659, 663-64 (M.D. [read post]
23 Jun 2014, 12:57 pm
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
